drugset / Trial / NCT07650708

A Multicenter, Open-Label Study to Evaluate Perioperative Treatment of Dry Eye With Miebo® in Subjects Undergoing LASIK

NCT07650708

NaSingle-groupOpen-labelTreatment

Summary

Compare eye dryness following laser-assisted in situ keratomileusis (LASIK) surgery to eye dryness prior to receiving perioperative Miebo in patients with dry eye disease (DED)

Timeline

Start
2026-05-05
Primary completion
2026-11-01
Completion
2026-12-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Perfluorohexyloctane Unknown

Indications